A detailed history of Edmond De Rothschild Holding S.A. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 413,227 shares of BMRN stock, worth $27.8 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
413,227
Previous 189,227 118.38%
Holding current value
$27.8 Million
Previous $15.6 Million 86.44%
% of portfolio
0.48%
Previous 0.27%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$69.02 - $93.84 $15.5 Million - $21 Million
224,000 Added 118.38%
413,227 $29 Million
Q1 2024

May 08, 2024

SELL
$83.81 - $99.0 $2.54 Million - $3 Million
-30,306 Reduced 13.8%
189,227 $16.5 Million
Q4 2023

Feb 12, 2024

BUY
$76.22 - $98.51 $762 - $985
10 Added 0.0%
219,533 $21.2 Million
Q3 2023

Nov 13, 2023

BUY
$85.07 - $94.48 $6.06 Million - $6.73 Million
71,217 Added 48.02%
219,523 $19.4 Million
Q2 2023

Aug 09, 2023

BUY
$86.68 - $100.3 $5.07 Million - $5.87 Million
58,506 Added 65.15%
148,306 $12.9 Million
Q1 2023

May 11, 2023

BUY
$87.74 - $117.27 $1.32 Million - $1.76 Million
15,000 Added 20.05%
89,800 $8.73 Million
Q4 2022

Feb 09, 2023

SELL
$80.93 - $108.63 $868,378 - $1.17 Million
-10,730 Reduced 12.55%
74,800 $7.74 Million
Q3 2022

Nov 09, 2022

BUY
$82.16 - $96.94 $2.37 Million - $2.79 Million
28,800 Added 50.77%
85,530 $7.25 Million
Q2 2022

Aug 12, 2022

BUY
$71.48 - $86.85 $3.96 Million - $4.81 Million
55,386 Added 4120.98%
56,730 $4.7 Million
Q1 2022

May 10, 2022

SELL
$74.28 - $92.69 $38,997 - $48,662
-525 Reduced 28.09%
1,344 $104,000
Q4 2021

Feb 10, 2022

SELL
$71.72 - $91.47 $9,323 - $11,891
-130 Reduced 6.5%
1,869 $165,000
Q3 2021

Nov 12, 2021

SELL
$74.77 - $85.47 $361,139 - $412,820
-4,830 Reduced 70.73%
1,999 $155,000
Q2 2021

Aug 11, 2021

SELL
$75.51 - $84.79 $4,908 - $5,511
-65 Reduced 0.94%
6,829 $570,000
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $515,188 - $625,216
6,894 New
6,894 $521,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.